IRadimed Stock

IRadimed Financial Leverage

The Financial Leverage (Equity Multiplier) of IRadimed (IRMD) as of Aug 16, 2026 is 1.15. In the previous year, Financial Leverage (Equity Multiplier) was 1.13 — a change of 1.51% (higher).

Financial Leverage

1.15

YoY

1.51%

Last updated:

Financial Leverage (Equity Multiplier) of IRadimed is 2026 1.15 . Financial Leverage (Equity Multiplier) of IRadimed was 2025 1.13 . It decreases by 1.51% higher compared to the previous year.
Access this data via the Eulerpool API

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IRadimed stock

Financial Leverage (Equity Multiplier) of IRadimed is 1.15 in 2026.

Financial Leverage (Equity Multiplier) of IRadimed changed from 1.13 to 1.15, representing a 1.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) IRadimed since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s IRadimed with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — IRadimed

All Key Metrics — IRadimed